Covid-19 roundup: AstraZeneca ships first COVAX doses as Canada recommends against 65+ use; Inovio, still stuck in PhIII, to respond to FDA in May
AstraZeneca’s Covid-19 vaccine has had a bumpy ride, but the prominent drugmaker is ready to start supplying their shots to COVAX.
The first doses of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
